Molecular aspects of rheumatoid arthritis: role of transcription factors
FEBS JOURNAL (2008)
期刊
FEBS JOURNAL
卷 275, 期 18, 页码 4463-4470出版社
WILEY-BLACKWELL
关键词
作者
我是这篇论文的作者
推荐
Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
Thivya Balendran, Keith Lim, John A. Hamilton, Adrian A. Achuthan
FRONTIERS IN IMMUNOLOGY (2023)
Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-kappa B) pathway
Chang Shu, Jun Chen, Meiyan Lv, Yiyuan Xi, Jujia Zheng, Xiangwei Xu
BIOENGINEERED (2022)
Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways
Chang-hong Li, Zhen-zhen Ma, Lei-lei Jian, Xin-yu Wang, Lin Sun, Xiang-yuan Liu, Zhong-qiang Yao, Jin-xia Zhao
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Lonicerin alleviates the progression of experimental rheumatoid arthritis by downregulating M1 macrophages through the NF-kappa B signaling pathway
Xiaojiang Yang, Hong Qian, Jia Meng, Hui Jiang, Tao Yuan, Shaoqiang Yang, Yibin Luo, Ninrong Bao, Jianning Zhao, Dongsheng Wang
PHYTOTHERAPY RESEARCH (2023)
β-arrestin-2 alleviates rheumatoid arthritis injury by suppressing NLRP3 inflammasome activation and NF-κB pathway in macrophages
Feng Cao, Cheng Huang, Jiwei Cheng, Zhaochun He
BIOENGINEERED (2022)
Rel/NF-κB Transcription Factors Emerged at the Onset of Opisthokonts
Michelle M. Leger, Nuria Ros-Rocher, Sebastian R. Najle, Inaki Ruiz-Trillo
GENOME BIOLOGY AND EVOLUTION (2022)
The role of resveratrol on rheumatoid arthritis: From bench to bedside
Shuyan Sheng, Xinyi Wang, Xin Liu, Xinyang Hu, Yubao Shao, Gaoyuan Wang, Deshen Mao, Conghan Li, Bangjie Chen, Xiaoyu Chen
FRONTIERS IN PHARMACOLOGY (2022)
ZhiJingSan Inhibits Osteoclastogenesis via Regulating RANKL/NF-kappa B Signaling Pathway and Ameliorates Bone Erosion in Collagen-Induced Mouse Arthritis
Yuanyuan Ling, Jie Yang, Di Hua, Dawei Wang, Chenglei Zhao, Ling Weng, Dandan Yue, Xueting Cai, Qinghai Meng, Jiao Chen, Xiaoyan Sun, Weikang Kong, Lizhong Zhu, Peng Cao, Chunping Hu
FRONTIERS IN PHARMACOLOGY (2021)
Anti-proliferation and anti-inflammation effects of corilagin in rheumatoid arthritis by downregulating NF-κB and MAPK signaling pathways
Yue Shen, Li Teng, Yuhan Qu, Jie Liu, Xudong Zhu, Shan Chen, Longfei Yang, Yuehui Huang, Qin Song, Qiang Fu
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Regulation of Sirt1 on energy metabolism and immune response in rheumatoid arthritis
Yi-jin Wu, Wen-juan Fang, Shu Pan, Sa-sa Zhang, Dan-feng Li, Zhong-fang Wang, Wen -gang Chen, Qin Yin, Jian Zuo
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Glaucocalyxin B inhibits cartilage inflammatory injury in rheumatoid arthritis by regulating M1 polarization of synovial macrophages through NF-κB pathway
Chenyang Han, Yi Yang, Yongjia Sheng, Jin Wang, Xiaohong Zhou, Wenyan Li, Li Guo, Caiqun Zhang, Qiao Ye
AGING-US (2021)
FTY720 Inhibits the Development of Collagen-Induced Arthritis in Mice by Suppressing the Recruitment of CD4+ T Lymphocytes
Chao Zhu, Shuang Wen, Junyong Li, Hongyu Meng, Junzhe Zhang, Kuo Zhao, Ling Wang, Yingze Zhang
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Euphorbia factor L3 ameliorates rheumatoid arthritis by suppressing the inflammatory response by targeting Rac family small GTPase 1
Haojun Shi, Shufeng Li, Yun Geng, Huancai Fan, Ruojia Zhang, Yuang Zhang, Jihong Pan, Guanhua Song, Luna Ge, Tianhua Xie, Lin Wang
BIOENGINEERED (2022)
Antirheumatoid Arthritic Effects of Sabia parviflora Wall. Leaf Extracts via the NF-?B Pathway and Transient Receptor Potential Protein Family
Yongqiang Zhou, Yamin Zhao, Hui Xu, Xiaoyan Zhao, Chunli Zhao, Tao Zhou, Yongping Zhang
FRONTIERS IN PHARMACOLOGY (2022)
Leocarpinolide B Attenuates Collagen Type II-Induced Arthritis by Inhibiting DNA Binding Activity of NF-κB
Ke-Gang Linghu, Guan-Ding Zhao, Dai-Yan Zhang, Shi-Hang Xiong, Guo-Ping Wu, Li-Yu Shen, Wen-Qing Cui, Tian Zhang, Yuan-Jia Hu, Bing Guo, Xiang-Chun Shen, Hua Yu
MOLECULES (2023)
A simple screening test to assess risk of falls in Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study
Koei Oh, Takefumi Furuya, Eisuke Inoue, Eiichi Tanaka, Katsunori Ikari, Atsuo Taniguchi, Hisashi Yamanaka, Ken Okazaki, Masayoshi Harigai
MODERN RHEUMATOLOGY (2021)
Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis
Eiichi Tanaka, Yutaka Kawahito, Masataka Kohno, Shintaro Hirata, Mitsumasa Kishimoto, Yuko Kaneko, Hiroya Tamai, Yohei Seto, Akio Morinobu, Takahiko Sugihara, Atsuko Murashima, Masayo Kojima, Masaaki Mori, Hiromu Ito, Toshihisa Kojima, Yasumori Sobue, Keiichiro Nishida, Isao Matsushita, Takeo Nakayama, Hisashi Yamanaka, Masayoshi Harigai
MODERN RHEUMATOLOGY (2022)
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis
Takahiko Sugihara, Yutaka Kawahito, Akio Morinobu, Yuko Kaneko, Yohei Seto, Toshihisa Kojima, Hiromu Ito, Masataka Kohno, Takeo Nakayama, Yasumori Sobue, Keiichiro Nishida, Isao Matsushita, Atsuko Murashima, Masaaki Mori, Eiichi Tanaka, Shintaro Hirata, Mitsumasa Kishimoto, Hisashi Yamanaka, Masayo Kojima, Masayoshi Harigai
MODERN RHEUMATOLOGY (2022)
Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study
Takefumi Furuya, Koei Oh, Katsunori Ikari, Eisuke Inoue, Eiichi Tanaka, Hisashi Yamanaka, Masayoshi Harigai
CLINICAL RHEUMATOLOGY (2022)
Effectiveness and safety of subcutaneous abatacept in biologic-naive RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)
Naoto Tamura, Takanori Azuma, Kenta Misaki, Rei Yamaguchi, Fuminori Hirano, Eiji Sugiyama, Daisuke Kanai, Yohko Murakawa, Motohiro Oribe, Takahito Kimata, Kazutoshi Aoki, Tomoko Sugiura, Koji Takasugi, Yuya Takakubo, Yasuyuki Tomita, Takeo Isozaki, Toshihiro Nanki, Naooki Katsuyama, Takanori Kuroiwa, Hideto Oshikawa, Motohide Kaneko, Hiroshi Fujinaga, Kiwamu Saito, Eiichi Tanaka, Eisuke Inoue, Yuri Yoshizawa, Shigeru Matsumoto, Hisashi Yamanaka, Masayoshi Harigai
MODERN RHEUMATOLOGY (2022)
Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study
Yoshiya Tanaka, Ayako Yamaguchi, Toshiaki Miyamoto, Kazuhide Tanimura, Hideyuki Iwai, Yuko Kaneko, Tsutomu Takeuchi, Koichi Amano, Naoki Iwamoto, Atsushi Kawakami, Miho Murakami, Norihiro Nishimoto, Tatsuya Atsumi, Takayuki Sumida, Koichiro Ohmura, Tsuneyo Mimori, Hisashi Yamanaka, Keishi Fujio, Yoshihisa Fujino, Kazuyoshi Saito, Kazuhisa Nakano, Shintaro Hirata, Shingo Nakayamada
RHEUMATOLOGY (2022)
Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication
Hiromu Ito, Keiichiro Nishida, Toshihisa Kojima, Isao Matsushita, Masayo Kojima, Shintaro Hirata, Yuko Kaneko, Mitsumasa Kishimoto, Masataka Kohno, Masaaki Mori, Akio Morinobu, Atsuko Murashima, Yohei Seto, Takahiko Sugihara, Eiichi Tanaka, Takeo Nakayama, Hisashi Yamanaka, Yutaka Kawahito, Masayoshi Harigai
MODERN RHEUMATOLOGY (2023)
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort
Eiichi Tanaka, Eisuke Inoue, Mai Abe, Kumiko Saka, Eri Sugano, Moeko Ochiai, Rei Yamaguchi, Katsunori Ikari, Hisashi Yamanaka, Masayoshi Harigai
MODERN RHEUMATOLOGY (2022)
Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication
Yutaka Kawahito, Akio Morinobu, Yuko Kaneko, Masataka Kohno, Shintaro Hirata, Mitsumasa Kishimoto, Yohei Seto, Takahiko Sugihara, Eiichi Tanaka, Hiromu Ito, Toshihisa Kojima, Isao Matsushita, Keiichiro Nishida, Masaaki Mori, Atsuko Murashima, Hisashi Yamanaka, Takeo Nakayama, Masayo Kojima, Masayoshi Harigai
MODERN RHEUMATOLOGY (2023)
Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis
Hisashi Yamanaka, Yoshiya Tanaka, Toshihiko Hibino, Gopalakrishnan Unmesh, Chirag Shah, Dhananjay Bakhle, Dimitris Stefanidis
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)
Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data
Eiichi Tanaka, Eisuke Inoue, Ayako Shoji, Jonas Nilsson, Christos Papagiannopoulos, Devender Dhanda, Yuri Yoshizawa, Mai Abe, Kumiko Saka, Eri Sugano, Naohiro Sugitani, Moeko Ochiai, Rei Yamaguchi, Katsunori Ikari, Hisashi Yamanaka, Masayoshi Harigai
PLOS ONE (2022)
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases
Claudia A. Salinas, Anthony Louder, Jennifer Polinski, Tancy C. Zhang, Hannah Bower, Syd Phillips, Yufei Song, Emaan Rashidi, Rafia Bosan, Hsiu-Ching Chang, Nicole Foster, Bernice Gershenson, Hisashi Yamanaka, Mitsumasa Kishimoto, Yoshiya Tanaka, Peter Fischer, Baojin Zhu, Douglas Faries, Xiaodan Mai, Brett T. Doherty, Angela Grelaud, Nicolas H. Thurin, Johan Askling, Walter Deberdt
RHEUMATOLOGY AND THERAPY (2023)
Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naive to or switched from biologics
Tsutomu Takeuchi, Kiyohiro Nishikawa, Fumika Yamada, Shiro Ohshima, Makoto Inoue, Yutaka Yoshioka, Hisashi Yamanaka
MODERN RHEUMATOLOGY (2022)
Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids
Rei Yamaguchi, Eiichi Tanaka, Ayako Nakajima, Eisuke Inoue, Mai Abe, Eri Sugano, Naohiro Sugitani, Kumiko Saka, Moeko Ochiai, Yoko Higuchi, Naoki Sugimoto, Katsunori Ikari, Hisashi Yamanaka, Masayoshi Harigai
MODERN RHEUMATOLOGY (2022)
Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort
Eri Sugano, Eiichi Tanaka, Eisuke Inoue, Ryoko Sakai, Mai Abe, Kumiko Saka, Naohiro Sugitani, Moeko Ochiai, Rei Yamaguchi, Yoko Higuchi, Naoki Sugimoto, Katsunori Ikari, Ayako Nakajima, Hisashi Yamanaka, Masayoshi Harigai
MODERN RHEUMATOLOGY (2022)